UCP2 and inflammatory bowel disease: A study conducted on miR-133a and its target UCP2 (mitochondrial uncoupling protein 2) using the DSS-induced IBD mouse model found that miR-133a levels were decreased upon DSS treatment, and by introducing an miR-133a mimic, the DSS-induced IBD was alleviated, suggesting that miRNA mimics could also function as therapy in IBD [63].